THOMPSON PETER A. sold 14.1% of their position (1.18M shares) of CORVUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $4.89M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2025ACC: 0000947871-25-000635
Director10% Owner
Since Jun 2019
-1.18M
Net shares
Net seller
$4.89M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.40M acquired · 2.57M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.40M
Price / share
$3.50
Trade value
$4.89M
% of position
20.1%
6/27/2025
6.94M→8.34M
Common Stock
Indirect
Shares
−1.18M
Price / share
$4.16
Trade value
$4.89M
% of position
14.1%
6/27/2025
8.34M→7.17M
Total
Net shares
+221.35K
Net value
-$0.26
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/27/2025 | X · X | +1.40M | $3.50 | $4.89M | 20.1% | 6.94M | 8.34M |
| Common Stock Indirect | 6/27/2025 | S · Sale | −1.18M | $4.16 | $4.89M | 14.1% | 8.34M | 7.17M |
| Total | +221.35K | -$0.26 | ||||||
Derivative Transactions1
Common Warrants (right to buy)
Indirect
Converts to
Common Stock
1.40M shares
Shares
−1.40M
Strike price
3.50
Held after
0.00
Exercisable
—
6/27/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Warrants (right to buy) Indirect | Common Stock1.40M shares | 6/27/2025 | X · X | −1.40M | 3.50 | — | 0.00 |